TruSpine #TSP August 2023 – CEO Laurence Strauss talks to Alan Green

Alan Green talks to Truspine #TSP CEO Laurence Strauss about the developments year to date, and the Company’s recent 510k submission to the US FDA for approval of the Cervi-LOK spinal stabilisation system. Laurence outlines his plans for a US trip to meet with the IP lawyers and the equipment distributors before we discuss the timeframe for future submissions for the other portfolio products GRASP Laminoplasty and Faci-LOK. We then look at the Company funding position, and Laurence outlines his plans to bring investors in by the end of October 2023. We finish with a summary of upcoming near term milestones.